Cargando…

New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis

Chemokine (C-X-C motif) ligand 4 (CXCL4) is a biomarker of unfavorable prognosis in Systemic Sclerosis (SSc), a potentially severe autoimmune condition, characterized by vasculitis, fibrosis and interferon (IFN)-I-signature. We recently reported that autoantibodies to CXCL4 circulate in SSc patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lande, Roberto, Palazzo, Raffaella, Mennella, Anna, Pietraforte, Immacolata, Cadar, Marius, Stefanantoni, Katia, Conrad, Curdin, Riccieri, Valeria, Frasca, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103273/ https://www.ncbi.nlm.nih.gov/pubmed/33800661 http://dx.doi.org/10.3390/antib10020012

Ejemplares similares

Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
por: Lande, Roberto, et al.
Publicado: (2020)

CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
por: Pietraforte, Immacolata, et al.
Publicado: (2022)

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
por: Palazzo, Raffaella, et al.
Publicado: (2022)

Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus
por: Lande, Roberto, et al.
Publicado: (2021)

CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
por: Lande, Roberto, et al.
Publicado: (2019)

COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort
por: Pellegrino, Greta, et al.
Publicado: (2020)

Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication
por: Mohammad Reza Beigi, Davide, et al.
Publicado: (2022)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)

Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?
por: Pietraforte, Immacolata, et al.
Publicado: (2023)

AB013. CXCL4-DNA immune complexes drive inflammation in systemic sclerosis by amplifying TLR9-mediated interferon-α production
por: Lee, Ernest Y., et al.
Publicado: (2021)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Advanced Autoantibody Testing in Systemic Sclerosis
por: Almaabdi, Kholoud, et al.
Publicado: (2023)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

Exercise capacity in relation to autoantibodies in systemic sclerosis patients
por: Someya, Fujiko, et al.
Publicado: (2012)

Autoantibodies are present before the clinical diagnosis of systemic sclerosis
por: Burbelo, Peter D., et al.
Publicado: (2019)

Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece
por: Liaskos, Christos, et al.
Publicado: (2018)

Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis
por: Moezinia, Carine, et al.
Publicado: (2023)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
por: Sibanda, Elopy N., et al.
Publicado: (2021)

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
por: Höppner, Jakob, et al.
Publicado: (2023)

Overlapping, Additive and Counterregulatory Effects of Type II and I Interferons on Myeloid Dendritic Cell Functions
por: Frasca, Loredana, et al.
Publicado: (2011)

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
por: Choi, May Y., et al.
Publicado: (2016)

Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic Sclerosis
por: Brezovec, Neža, et al.
Publicado: (2022)

Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application
por: Damoiseaux, Jan, et al.
Publicado: (2022)

Human-murine chimeric autoantibodies with high affinity and specificity for systemic sclerosis
por: Chen, Sunhui, et al.
Publicado: (2023)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Predicting the Progression of Very Early Systemic Sclerosis: Current Insights
por: Bellocchi, Chiara, et al.
Publicado: (2022)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
por: Johnson, Michael E., et al.
Publicado: (2016)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus
por: Lande, R., et al.
Publicado: (2020)

The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
por: Frech, Tracy M., et al.
Publicado: (2021)

Altered ocular microvasculature in patients with systemic sclerosis and very early disease of systemic sclerosis using optical coherence tomography angiography
por: Mihailovic, Nataša, et al.
Publicado: (2022)

Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
por: Frasca, Loredana, et al.
Publicado: (2023)

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression
por: Giovannetti, Antonello, et al.
Publicado: (2013)

Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
por: Klemm, Philipp, et al.
Publicado: (2019)

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation
por: Ayoglu, Burcu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9odctqlih1jiu1qf2gnok31m7o